Speakers

George Buchman

Vice President, Pre-Clinical and Process Development • Catalent Cell and Gene Therapy

Buchman joined Catalent through its acquisition of Paragon Gene Therapy in 2019. He has more than 30 years of experience in the biotech industry and has held roles at companies including Life Technologies (now Thermo Fisher), Celera Genomics and GeneLogic. Dr. Buchman obtained a bachelor’s degree in biochemistry from Albright College, Reading, Pennsylvania, and a doctorate in biochemistry from University of Maryland.  

Also Speaking

Image

Glenn Lumpkin

Director of Technical Services • CAI
9 November 2022
Image

Lara Silverman

Founder • LIS BioConsulting
18 November 2022
Image

Gregg Nyberg

Chief Technology Officer • Landmark Bio
22 November 2022

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.
21 March 2023
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023